Status:
COMPLETED
Comparison of the Glidescope and Macintosh Laryngoscope for Double Lumen Endotracheal Tube Intubation
Lead Sponsor:
University Health Network, Toronto
Conditions:
Lung Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Patients undergoing chest surgery often require insertion of a breathing tube (double lumen tube) after they are unconscious. The double lumen tube enables the anaesthetist to ventilate (assist breath...
Detailed Description
The Glidescope (GVL) has been extensively studied for single lumen tube intubation and found to be a very safe and useful device. It is a particularly useful for patients with difficult airways as it ...
Eligibility Criteria
Inclusion
- Population: planned elective lung surgery requiring general anaesthesia with a double lumen endotracheal intubation, signed informed patient consent.
Exclusion
- Previous failed intubation,
- history of difficult intubation or anticipated difficult intubation (2 risk factors of mallampati score 3 or greater,
- incisor gap \< 3.5cm, thyromental distance \< 6.5cm,
- reduced neck extension and flexion),
- alternative method of intubation indicated eg rapid sequence intubation,
- fibreoptic intubation,
- contra-indication to a left double lumen tube eg endobronchial tumor,
- significant deviation or compression of the trachea and bronchi.,
- contraindication to one lung ventilation eg severe hypoxia or pulmonary hypertension,
- anticipated difficult bag mask ventilation,
- symptomatic gastro-oesophageal reflux,
- oral/pharyngeal/laryngeal carcinoma,
- loose teeth,
- allergy to rocuronium, BMI \> 40.
Key Trial Info
Start Date :
June 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2013
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT01404780
Start Date
June 1 2011
End Date
February 1 2013
Last Update
February 22 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Toronto General Hospital
Toronto, Ontario, Canada, M5G 2C4